Compass Pathways PLC

5Y6

Company Profile

  • Business description

    Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

  • Contact

    33 Broadwick Street
    LondonW1F 0DQ
    GBR

    E: [email protected]

    https://compasspathways.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2026

    Employees

    166

Stocks News & Analysis

stocks

Cheap Narrow Moat ASX share continues to face negative sentiment

Earnings growth fails to excite investors worried about AI disruption.
stocks

ASX energy giant remains cheap following record production

Impressive cost control and record production leads to higher dividend.
stocks

Strong results from cheap ASX share

The market responded favourably to results but shares still underpriced.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,321.1012.800.14%
CAC 408,519.2122.040.26%
DAX 4024,986.255.72-0.02%
Dow JONES (US)49,174.50370.440.76%
FTSE 10010,680.594.15-0.04%
HKSE26,590.32491.59-1.82%
NASDAQ22,863.68236.411.04%
Nikkei 22557,906.95585.861.02%
NZX 50 Index13,523.279.04-0.07%
S&P 5006,890.0752.320.77%
S&P/ASX 2009,094.1010.000.11%
SSE Composite Index4,117.4135.340.87%

Market Movers